Anti-Human IL17A Therapeutic Antibody (Vunakizumab)

Recombinant monoclonal antibody to IL17A. Vunakizumab is a humanized monoclonal antibody that can be potentially used in the treatment of Autoimmune diseases, Psoriasis.
Supplier Creative Biolabs
Product # TAB-458CQ
Pricing Inquiry
Host Human
Target IL-17A
Species Reactivity Human
Type IgG1, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Inhibition
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback